“…Polymorphism at NRPE1 , a key component of the RdDM pathway, was revealed in univariate GWAS, while variation in CMT3 (and its regulator, MIR823a ) was only found after controlling for mCHH. At the same time, it seems clear that reality is more complex, and that both mCHH and mCHG are regulated by multiple homeostatic mechanisms that also involve factors not included in our model, like histone modifications (Zhang et al, 2021). It is therefore not surprising that most of the polymorphisms we have identified seem to affect both traits, albeit not to the same extent (exceptions include the one at MIR823A , which only seems to affect mCHG, and the previously identified CMT2a’ and CMT2b’ polymorphisms, which only affect mCHH on CMT2-targeted transposons; see Figs S2, S3).…”